NCT06060002View on ClinicalTrials.gov

Role of Prophylactic Biliary Stent in Reducing the Recurrence of Choledocholithiasis

NANot yet recruitingINTERVENTIONAL

Enrollment

480

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions

Choledocholithiasis

Interventions

PROCEDURE

Group A - Stent exchange if cholecystectomy dated beyond 3 months

Stent removal and cholangiogram and stone clearance (if recurrent stone/s is/are found). Stent exchange if cholecystectomy dated beyond 3 months

DIAGNOSTIC_TEST

Group B - Diagnostic EUS/MRCP/USG abdomen and LFT at 3 months

Diagnostic EUS/MRCP/USG abdomen and LFT at 3 months to see recurrence of CDL. ERC and stone clearance (if recurrent stone/s found on EUS/MRCP/USG abdomen)

All Listed Sponsors

lead

Asian Institute of Gastroenterology, India

OTHER

NCT06060002 - Role of Prophylactic Biliary Stent in Reducing the Recurrence of Choledocholithiasis | Biotech Hunter | Biotech Hunter